about
Young at Heart: Pioneering Approaches to Model Nonischaemic Cardiomyopathy with Induced Pluripotent Stem CellsCell reprogramming and neuronal differentiation applied to neurodegenerative diseases: Focus on Parkinson's diseasecGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications.HLA Class I Depleted hESC as a Source of Hypoimmunogenic Cells for Tissue Engineering Applications.Tissue Engineering and Regenerative Medicine 2015: A Year in ReviewClinical Trials in a Dish: The Potential of Pluripotent Stem Cells to Develop Therapies for Neurodegenerative Diseases.Cellular Mechanisms of Liver Regeneration and Cell-Based Therapies of Liver Diseases.A future with less HLA: potential clinical applications of HLA-universal cells.The mitochondrial protein CHCHD2 primes the differentiation potential of human induced pluripotent stem cells to neuroectodermal lineages.Preferential Lineage-Specific Differentiation of Osteoblast-Derived Induced Pluripotent Stem Cells into Osteoprogenitors.Beneath the sword of Damocles: regenerative medicine and the shadow of immunogenicity.New strategies for improving stem cell therapy in ischemic heart disease.Genomic Instability of iPSCs: Challenges Towards Their Clinical Applications.Risk of HLA Homozygous Cord Blood Transplantation: Implications for Induced Pluripotent Stem Cell Banking and Transplantation.Making it personal: the prospects for autologous pluripotent stem cell-derived therapies.Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects.Integration of induced pluripotent stem cell-derived endothelial cells with polycaprolactone/gelatin-based electrospun scaffolds for enhanced therapeutic angiogenesis.Cortical GABAergic Interneuron/Progenitor Transplantation as a Novel Therapy for Intractable Epilepsy.
P2860
Q26750663-42F22D16-8477-4E99-96E7-8D3C72A7228AQ28080770-C72A7EB1-A467-4F9C-89DC-F7563467CFEBQ34045021-5F927A15-4CF7-4116-8EC0-91CCC53B1B79Q36160823-8EA57B5A-3732-40CD-8CD0-F45ECE2D55EBQ36756232-8B16ADD9-A3C8-4127-BE55-7781CAAC97FEQ36904682-200AB906-279E-4264-B5D3-BC7C724DDD7CQ37624953-68DDBCD0-9877-4B36-9421-598D1C233C62Q38416517-EBFCE2DE-CDBB-4AD4-A718-E43EA3965842Q38733127-A9C18C7B-29E9-4FA4-B7C5-83D917371591Q38751740-9ECC4349-1938-4955-876F-2C3D91FE3EB1Q38788699-B0B109DF-C481-4298-9832-3A2075580F85Q38804978-DAA1749B-D858-4F13-B5B0-2E2241B60FC3Q38945910-353CEEE1-6480-46DC-BB44-B39FAA25DB24Q48352444-7CAE368E-14EF-4825-AFE5-5A4285C4013DQ48654476-765240F2-D219-40A8-A193-DE6BFB4875E7Q52589683-12B7FEEA-1EF3-494B-A1B9-EF1BEA27439BQ52644323-74EEE634-41ED-4EB3-8293-D16053145B21Q55645380-CE9C165E-D02D-49F1-B901-6B64E20A340F
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Banking on iPSC--is it doable and is it worthwhile
@ast
Banking on iPSC--is it doable and is it worthwhile
@en
Banking on iPSC--is it doable and is it worthwhile
@nl
type
label
Banking on iPSC--is it doable and is it worthwhile
@ast
Banking on iPSC--is it doable and is it worthwhile
@en
Banking on iPSC--is it doable and is it worthwhile
@nl
prefLabel
Banking on iPSC--is it doable and is it worthwhile
@ast
Banking on iPSC--is it doable and is it worthwhile
@en
Banking on iPSC--is it doable and is it worthwhile
@nl
P2093
P2860
P3181
P1476
Banking on iPSC--is it doable and is it worthwhile
@en
P2093
Fernando Pitossi
Mahendra S Rao
Susan Solomon
P2860
P2888
P3181
P356
10.1007/S12015-014-9574-4
P407
P577
2015-02-01T00:00:00Z
P5875
P6179
1004939910